239 related articles for article (PubMed ID: 15700772)
21. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp.
Hibberts NA; Howell AE; Randall VA
J Endocrinol; 1998 Jan; 156(1):59-65. PubMed ID: 9496234
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques.
Pan HJ; Wilding G; Uno H; Inui S; Goldsmith L; Messing E; Chang C
Endocrine; 1998 Aug; 9(1):39-43. PubMed ID: 9798729
[TBL] [Abstract][Full Text] [Related]
23. Liposomal methylene blue hydrogel for selective photodynamic therapy of acne vulgaris.
Fadel M; Salah M; Samy N; Mona S
J Drugs Dermatol; 2009 Nov; 8(11):983-90. PubMed ID: 19894365
[TBL] [Abstract][Full Text] [Related]
24. Nanoparticles for skin penetration enhancement--a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles.
Küchler S; Radowski MR; Blaschke T; Dathe M; Plendl J; Haag R; Schäfer-Korting M; Kramer KD
Eur J Pharm Biopharm; 2009 Feb; 71(2):243-50. PubMed ID: 18796329
[TBL] [Abstract][Full Text] [Related]
25. Enhanced Follicular Delivery of Finasteride to Human Scalp Skin Using Heat and Chemical Penetration Enhancers.
Farah HA; Brown MB; McAuley WJ
Pharm Res; 2020 May; 37(6):112. PubMed ID: 32476090
[TBL] [Abstract][Full Text] [Related]
26. [Androgenetic alopecia in the male. Recent developments].
Braun-Falco O; Bergner T
Hautarzt; 1989 Nov; 40(11):669-78. PubMed ID: 2691447
[TBL] [Abstract][Full Text] [Related]
27. Thyroid receptor agonists for the treatment of androgenetic alopecia.
Li JJ; Mitchell LH; Dow RL
Bioorg Med Chem Lett; 2010 Jan; 20(1):306-8. PubMed ID: 19900809
[TBL] [Abstract][Full Text] [Related]
28. Delivery and targeting of nanoparticles into hair follicles.
Fang CL; Aljuffali IA; Li YC; Fang JY
Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
[TBL] [Abstract][Full Text] [Related]
29. Human skin penetration of silver nanoparticles through intact and damaged skin.
Larese FF; D'Agostin F; Crosera M; Adami G; Renzi N; Bovenzi M; Maina G
Toxicology; 2009 Jan; 255(1-2):33-7. PubMed ID: 18973786
[TBL] [Abstract][Full Text] [Related]
30. [Proliferation behavior of the anagen hair bulb in androgenetic alopecia before and after local administration of 17 alpha- propylmesterolone--DNA flow cytophotometry studies].
Kiesewetter F; Schell H; Seidel C; von Hintzenstern J
Z Hautkr; 1990 Dec; 65(12):1115-9. PubMed ID: 2087839
[TBL] [Abstract][Full Text] [Related]
31. Androgens and hair growth.
Randall VA
Dermatol Ther; 2008; 21(5):314-28. PubMed ID: 18844710
[TBL] [Abstract][Full Text] [Related]
32. Clascoterone: First Approval.
Dhillon S
Drugs; 2020 Nov; 80(16):1745-1750. PubMed ID: 33030710
[TBL] [Abstract][Full Text] [Related]
33. Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro.
Rosette C; Rosette N; Mazzetti A; Moro L; Gerloni M
J Drugs Dermatol; 2019 Feb; 18(2):197-201. PubMed ID: 30811143
[TBL] [Abstract][Full Text] [Related]
34. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery.
Shah KA; Date AA; Joshi MD; Patravale VB
Int J Pharm; 2007 Dec; 345(1-2):163-71. PubMed ID: 17644288
[TBL] [Abstract][Full Text] [Related]
35. Time and depth resolved visualisation of the diffusion of a lipophilic dye into the hair follicle of fresh unfixed human scalp skin.
Grams YY; Whitehead L; Cornwell P; Bouwstra JA
J Control Release; 2004 Aug; 98(3):367-78. PubMed ID: 15312993
[TBL] [Abstract][Full Text] [Related]
36. Treatment of alopecia by transplantation of hair follicle stem cells and dermal papilla cells encapsulated in alginate gels.
Zhao J; Liu LQ; Wang YJ; Yang W; Geng WX; Wei J; Li LW; Chen FL
Med Hypotheses; 2008; 70(5):1014-6. PubMed ID: 17936520
[TBL] [Abstract][Full Text] [Related]
37. Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptives.
Wiegratz I; Kuhl H
Treat Endocrinol; 2002; 1(6):372-86. PubMed ID: 15832490
[TBL] [Abstract][Full Text] [Related]
38. Influence of interleukin-1alpha on androgen receptor expression and cytokine secretion by cultured human dermal papilla cells.
Boivin WA; Jiang H; Utting OB; Hunt DW
Exp Dermatol; 2006 Oct; 15(10):784-93. PubMed ID: 16984260
[TBL] [Abstract][Full Text] [Related]
39. Hormone-induced aberrations in electromagnetic adhesion signaling as a developmental factor of androgenetic alopecia.
Matilainen VA; Keinänen-Kiukaanniemi SM
Med Hypotheses; 2002 Apr; 58(4):261-3. PubMed ID: 12027516
[TBL] [Abstract][Full Text] [Related]
40. Silencing the androgen receptor: new skills for antiandrogen oligonucleotide skin and hair therapy.
Dugour A; Hagelin K; Smus C; Balañá ME; Kerner N
J Dermatol Sci; 2009 May; 54(2):123-5. PubMed ID: 19186031
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]